Evidence supporting the use of: Methylxanthine (unspecified)
For the body system: Bronchials

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Table of Contents

Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Methylxanthines are a class of compounds that include caffeine, theophylline, and theobromine. Of these, theophylline is especially well-studied and has a long history of use in supporting the bronchial (respiratory) system. Theophylline acts as a bronchodilator, meaning it helps to relax and open the airways in the lungs, making it easier to breathe. It achieves these effects through several mechanisms, including inhibition of phosphodiesterase enzymes, leading to increased cyclic AMP levels in bronchial smooth muscle, and antagonism of adenosine receptors, both of which contribute to smooth muscle relaxation and reduced airway reactivity.

The use of methylxanthines, particularly theophylline, has been validated in clinical practice for the management of chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Numerous clinical trials and guidelines have established the efficacy of theophylline as an adjunct therapy in cases where first-line agents (like inhaled corticosteroids and beta-agonists) are insufficient. However, its use has declined somewhat due to its narrow therapeutic window and potential for side effects.

In summary, the use of methylxanthines for supporting the bronchial system is strongly supported by scientific evidence, particularly for theophylline, with historical medical use dating back over a century. The mechanism of action and efficacy in respiratory support are well characterized in the medical literature.

More about Methylxanthine (unspecified)
More about Bronchials

Products containing Methylxanthine (unspecified)

We currently have no products on Vitabase that contain this ingredient.